Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)

Conditions:   Tuberculosis, Multidrug-Resistant;   Tuberculosis;   Tuberculosis, Pulmonary;   Mycobacterium Infections;   Bacterial Infections;   Gram-Positive Bacterial Infections Interventions:   Drug: Bedaquiline 100 MG;   Drug: Delamanid 50 MG Oral Tablet;   Drug: Clofazimine Pill;   Drug: Linezolid Pill;   Drug: Control arm MDR-TB regimen, designed according to latest WHO guidelines Sponsors:   Médecins Sans Frontières, France;   Partners in Health;   Harvard Medical School;   Epicentre;   Institute of Tropical Medicine, Belgium;   Socios En Salud, Peru;   Interactive Research and Development Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials